Efficacy of Metallic Stent for Treatment of Anastomotic Biliary Stricture After Living Donor Liver Transplantation

Efficacy of Metallic Stent for Treatment of Anastomotic Biliary Stricture After Living Donor Liver Transplantation - Efficacy of Metallic Stent for Treatment of Anastomotic Biliary Stricture After Living Donor Liver Transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036910

Enrollment

Registered

2019-07-01

Start date

2019-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomotic Biliary Stricture After Living Donor Liver Transplantation

Interventions

cSEMS/Plastic stent

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.patients with anastomotic biliary stricture who had duct-to-duct anastomosis after living donor liver transplantation

Exclusion criteria

Exclusion criteria: 1.Patients who can not receive endoscopic treatment 2.Patient with severe blood coagulation disorder 3.Patients with biliary stricture due to benign tumors 4.Patients who may have sensitization or allergic reactions to nitinol products 5.Patients who are pregnant or are likely to be pregnant, nursing patients, and patients who wish to be pregnant during the study period 6.In addition, patients who the research director has judged inappropriate as a research subject

Design outcomes

Primary

Measure	Time frame
Stricture resolution rate after cSEMS removal	—

Countries

Japan

Contacts

Public ContactNaohiro Komatsu

Nagasaki University Hospital Department of Gatroenterology and Hepatology

n_komatsu0822@yahoo.co.jp095-819-7481

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026